Literature DB >> 9647261

IFN-gamma receptor signaling is essential for the initiation, acceleration, and destruction of autoimmune kidney disease in MRL-Fas(lpr) mice.

A Schwarting1, T Wada, K Kinoshita, G Tesch, V R Kelley.   

Abstract

CSF-1 and TNF-alpha in the kidney of MRL-Fas(lpr) mice are proximal events that precede and promote autoimmune lupus nephritis, while apoptosis of renal parenchymal cells is a feature of advanced human lupus nephritis. In the MRL-Fas(lpr) kidney, infiltrating T cells that secrete IFN-gamma are a hallmark of disease. To examine the impact of IFN-gamma on renal injury in MRL-Fas(lpr) mice, we constructed a IFN-gamma R-deficient strain. In MRL-Fas(lpr) mice lacking IFN-gamma R, circulating and intrarenal CSF-1 were absent, TNF-alpha was markedly reduced, survival was extended, lymphadenopathy and splenomegaly were prevented, and the kidneys remained protected from destruction. Mesangial cells (MC) that were signaled through the IFN-gamma R induced CSF-1 and TNF-alpha in MRL-Fas(lpr) mice. We detected a large number of apoptotic renal parenchymal cells in advanced nephritis and determined that signaling via the IFN-gamma R induces apoptosis of tubular epithelial cells (TEC), but not MC. By comparison, TNF-alpha induces apoptosis in MC, but not TEC, of the MRL-Fas(lpr) strain. Thus, IFN-gamma is directly and indirectly responsible for apoptosis of TEC and MC in MRL-Fas(lpr) mice, respectively. In conclusion, IFN-gamma R signaling is essential for the initiation (CSF-1), acceleration (CSF-1 and TNF-alpha), and apoptotic destruction of renal parenchymal cells in MRL-Fas(lpr) autoimmune kidney disease.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9647261

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  80 in total

Review 1.  Tumour necrosis factor and other cytokines in murine lupus.

Authors:  A N Theofilopoulos; B R Lawson
Journal:  Ann Rheum Dis       Date:  1999-11       Impact factor: 19.103

2.  Diet modulates Th-1 and Th-2 cytokine production in the peripheral blood of lupus-prone mice.

Authors:  C A Jolly; G Fernandes
Journal:  J Clin Immunol       Date:  1999-05       Impact factor: 8.317

3.  Targeting transcription factor Stat4 uncovers a role for interleukin-18 in the pathogenesis of severe lupus nephritis in mice.

Authors:  Julia Menke; Tillmann Bork; Birte Kutska; Katelyn T Byrne; Michaela Blanfeld; Manfred Relle; Vicki R Kelley; Andreas Schwarting
Journal:  Kidney Int       Date:  2010-10-27       Impact factor: 10.612

Review 4.  Interferon-γ and systemic autoimmunity.

Authors:  Kenneth M Pollard; David M Cauvi; Christopher B Toomey; Kevin V Morris; Dwight H Kono
Journal:  Discov Med       Date:  2013-09       Impact factor: 2.970

5.  Disruption of Pathogenic Cellular Networks by IL-21 Blockade Leads to Disease Amelioration in Murine Lupus.

Authors:  Jin-Young Choi; Abhinav Seth; Michael Kashgarian; Sonia Terrillon; Emma Fung; Lili Huang; Li Chun Wang; Joe Craft
Journal:  J Immunol       Date:  2017-02-20       Impact factor: 5.422

Review 6.  Interferon pathway activation in systemic lupus erythematosus.

Authors:  Mary K Crow
Journal:  Curr Rheumatol Rep       Date:  2005-12       Impact factor: 4.592

Review 7.  T cell subsets and their signature cytokines in autoimmune and inflammatory diseases.

Authors:  Itay Raphael; Saisha Nalawade; Todd N Eagar; Thomas G Forsthuber
Journal:  Cytokine       Date:  2014-10-30       Impact factor: 3.861

8.  ICOS controls effector function but not trafficking receptor expression of kidney-infiltrating effector T cells in murine lupus.

Authors:  Jared M Odegard; Leah D DiPlacido; Lark Greenwald; Michael Kashgarian; Dwight H Kono; Chen Dong; Richard A Flavell; Joe Craft
Journal:  J Immunol       Date:  2009-04-01       Impact factor: 5.422

9.  Signals via the adaptor MyD88 in B cells and DCs make distinct and synergistic contributions to immune activation and tissue damage in lupus.

Authors:  Lino L Teichmann; Dominik Schenten; Ruslan Medzhitov; Michael Kashgarian; Mark J Shlomchik
Journal:  Immunity       Date:  2013-03-14       Impact factor: 31.745

10.  Development of proteoglycan-induced arthritis is independent of IL-17.

Authors:  Paul D Doodes; Yanxia Cao; Keith M Hamel; Yumei Wang; Balint Farkas; Yoichiro Iwakura; Alison Finnegan
Journal:  J Immunol       Date:  2008-07-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.